Archives
MK-1775: Wee1 Kinase Inhibitor Workflows
2026-08-20
MK-1775 connects Wee1 target engagement with practical studies of G2 checkpoint failure, DNA damage response inhibition, and selective stress in p53-deficient tumor models. This guide emphasizes mechanism-resolved viability measurements, treatment timing, and troubleshooting so apparent growth inhibition is not mistaken for cell killing.
Stat3 in Fyn-Driven Dopaminergic Neurodegeneration
2026-08-19
A 2024 zebrafish study identifies Stat3 as a downstream effector linking constitutively active Fyn kinase to dopaminergic neuron loss and microglial inflammation. Live imaging, transcriptomics, and chemical inhibition support a cooperative Stat3–NF-κB mechanism that provides a framework for functional gene studies of neurodegeneration.
PD0325901: MEK Inhibitor Workflows
2026-08-19
Use PD0325901 to connect pathway-level MEK inhibition with P-ERK, cell-cycle, apoptosis, and xenograft readouts. A complementary chromatin perspective shows how single-molecule nucleosome assays can extend, but not replace, conventional oncology workflows.
Drug Response Metrics in Cancer: Schwartz Dissertation
2026-08-18
Hannah R. Schwartz’s dissertation examines why relative viability and fractional viability should not be treated as interchangeable measures of anticancer activity. Its central contribution is a framework for separating growth inhibition from actual cell killing, improving interpretation of drug-response experiments and the design of in vitro cancer research workflows.
TUNEL Assay Kit for Cell Death–Immunity Links
2026-08-18
The One-step TUNEL Cy5 Apoptosis Detection Kit provides far-red DNA fragmentation detection for cells and tissue sections. This article explains how to use TUNEL results alongside TBK1–interferon biology without confusing an apoptosis endpoint with pathway-specific evidence.
Obeticholic Acid: Designing Causal FXR Studies
2026-08-17
Obeticholic Acid is a receptor-proximal tool for dissecting bile acid homeostasis, cholestasis, and fibrotic liver phenotypes. This article develops an assay-centered framework that connects FXR target genes with the immune and fibrogenic insights from recent liver fibrosis research.
ACSF3, Human Height, and Basal Metabolic Rate
2026-08-17
A 2025 Cell Genomics study identifies rs34590044-A as a regulatory variant linking increased human height with basal metabolic rate through ACSF3 expression, amino acid metabolism, and mitochondrial activity. The work combines human genetics, regulatory assays, mouse physiology, and ancient-DNA evidence to propose that dietary adaptation contributed to the coevolution of body size and energy expenditure.
SCH772984: ERK1/2 Inhibitor Workflow
2026-08-16
SCH772984 enables direct, selective interrogation of ERK1/2 signaling in MAPK-driven tumor models. This workflow connects target-engagement assays with radioresistance and ferroptosis studies inspired by a nasopharyngeal carcinoma reference model, while clearly separating established evidence from proposed applications.
PreScission Protease (PSP): Tag Cleavage Guide
2026-08-15
PreScission Protease (PSP), SKU K1101, is an HRV 3C protease fusion enzyme for site-specific removal of recombinant protein tags under low-temperature cleavage conditions. It should be used only when the target construct contains an accessible recognition sequence; it is not a general-purpose protease for substrates lacking the defined site.
Separating Growth Arrest from Cell Death in Cancer Assays
2026-08-14
Hannah R. Schwartz’s dissertation distinguishes relative viability from fractional viability, showing that these commonly interchangeable metrics capture different components of an anticancer response. The framework supports more precise interpretation of drug-induced proliferation arrest, cell killing, and response timing in cancer research.
Biotin-XX Tyramide Reagent for Cell-Surface TSA
2026-08-14
Biotin-XX Tyramide Reagent, also called biotin-LC-LC-tyramide, is a membrane-impermeant HRP substrate for localized biotin deposition. Its long polar linker supports selective cell-surface labeling, while tyramide signal amplification improves detection in immunohistochemistry, in situ hybridization, and proximity-labeling workflows.
Filipin III for Membrane Cholesterol Mapping
2026-08-13
Filipin III converts membrane cholesterol distribution into an interpretable fluorescence or ultrastructural readout, helping researchers connect lipid organization with macrophage immunometabolism. This workflow emphasizes controls, solution stability, quantitative imaging, and orthogonal validation rather than treating filipin intensity as a standalone cholesterol measurement.
Perospirone Inhibits Coronary Kv1.5 Channels
2026-08-13
A 2025 Journal of Applied Toxicology study shows that perospirone inhibits voltage-gated K+ currents in freshly isolated rabbit coronary arterial smooth muscle cells, with partial pharmacological evidence implicating Kv1.5 channels. The findings extend the antipsychotic drug mechanism of perospirone beyond serotonergic and dopaminergic signaling pathways and raise a testable, but not yet clinical, cardiovascular safety question.
Bovine Insulin for Cell Culture and Metabolic Assays
2026-08-12
Bovine insulin supports reproducible cell expansion while also enabling controlled studies of glucose metabolism regulation, insulin signaling, and mitochondrial quality control. This workflow-focused guide connects routine supplementation with a neuronal mechanism involving AMPK and Pink1 mRNA localization.
ATRX Loss Sensitizes Glioma Cells to RTK Inhibitors
2026-08-12
The reference study identifies a genotype-associated vulnerability in high-grade glioma: ATRX-deficient cells show greater sensitivity to multiple receptor tyrosine kinase and PDGFR inhibitors. Its combination data further suggest that ATRX status may help interpret RTK inhibitor trials and prioritize temozolomide-based treatment strategies.
607 records 11/41 page Previous Next First page 上5页 1112131415 下5页 Last page